ANIX
Price
$2.98
Change
-$0.03 (-1.00%)
Updated
Aug 8 closing price
Capitalization
95.99M
33 days until earnings call
LGND
Price
$150.06
Change
+$3.74 (+2.56%)
Updated
Aug 8 closing price
Capitalization
2.9B
87 days until earnings call
Interact to see
Advertisement

ANIX vs LGND

Header iconANIX vs LGND Comparison
Open Charts ANIX vs LGNDBanner chart's image
Anixa Biosciences
Price$2.98
Change-$0.03 (-1.00%)
Volume$165.56K
Capitalization95.99M
Ligand Pharmaceuticals
Price$150.06
Change+$3.74 (+2.56%)
Volume$195.53K
Capitalization2.9B
ANIX vs LGND Comparison Chart in %
Loading...
ANIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LGND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANIX vs. LGND commentary
Aug 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANIX is a StrongBuy and LGND is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 10, 2025
Stock price -- (ANIX: $2.98 vs. LGND: $150.06)
Brand notoriety: ANIX and LGND are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANIX: 101% vs. LGND: 119%
Market capitalization -- ANIX: $95.99M vs. LGND: $2.9B
ANIX [@Biotechnology] is valued at $95.99M. LGND’s [@Biotechnology] market capitalization is $2.9B. The market cap for tickers in the [@Biotechnology] industry ranges from $93.98B to $0. The average market capitalization across the [@Biotechnology] industry is $1.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANIX’s FA Score shows that 0 FA rating(s) are green whileLGND’s FA Score has 0 green FA rating(s).

  • ANIX’s FA Score: 0 green, 5 red.
  • LGND’s FA Score: 0 green, 5 red.
According to our system of comparison, LGND is a better buy in the long-term than ANIX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANIX’s TA Score shows that 2 TA indicator(s) are bullish while LGND’s TA Score has 5 bullish TA indicator(s).

  • ANIX’s TA Score: 2 bullish, 7 bearish.
  • LGND’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, LGND is a better buy in the short-term than ANIX.

Price Growth

ANIX (@Biotechnology) experienced а -1.00% price change this week, while LGND (@Biotechnology) price change was +13.07% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.25%. For the same industry, the average monthly price growth was +6.85%, and the average quarterly price growth was +13.24%.

Reported Earning Dates

ANIX is expected to report earnings on Sep 12, 2025.

LGND is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+0.25% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LGND($2.9B) has a higher market cap than ANIX($96M). LGND YTD gains are higher at: 40.047 vs. ANIX (28.448). ANIX has higher annual earnings (EBITDA): -13.11M vs. LGND (-122.1M). LGND has more cash in the bank: 209M vs. ANIX (15.6M). ANIX has less debt than LGND: ANIX (221K) vs LGND (4.45M). LGND has higher revenues than ANIX: LGND (181M) vs ANIX (0).
ANIXLGNDANIX / LGND
Capitalization96M2.9B3%
EBITDA-13.11M-122.1M11%
Gain YTD28.44840.04771%
P/E RatioN/A46.19-
Revenue0181M-
Total Cash15.6M209M7%
Total Debt221K4.45M5%
FUNDAMENTALS RATINGS
ANIX vs LGND: Fundamental Ratings
ANIX
LGND
OUTLOOK RATING
1..100
6845
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
75
Overvalued
PROFIT vs RISK RATING
1..100
9548
SMR RATING
1..100
9895
PRICE GROWTH RATING
1..100
5738
P/E GROWTH RATING
1..100
10092
SEASONALITY SCORE
1..100
650

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ANIX's Valuation (73) in the Computer Peripherals industry is in the same range as LGND (75) in the Biotechnology industry. This means that ANIX’s stock grew similarly to LGND’s over the last 12 months.

LGND's Profit vs Risk Rating (48) in the Biotechnology industry is somewhat better than the same rating for ANIX (95) in the Computer Peripherals industry. This means that LGND’s stock grew somewhat faster than ANIX’s over the last 12 months.

LGND's SMR Rating (95) in the Biotechnology industry is in the same range as ANIX (98) in the Computer Peripherals industry. This means that LGND’s stock grew similarly to ANIX’s over the last 12 months.

LGND's Price Growth Rating (38) in the Biotechnology industry is in the same range as ANIX (57) in the Computer Peripherals industry. This means that LGND’s stock grew similarly to ANIX’s over the last 12 months.

LGND's P/E Growth Rating (92) in the Biotechnology industry is in the same range as ANIX (100) in the Computer Peripherals industry. This means that LGND’s stock grew similarly to ANIX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ANIXLGND
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
73%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
70%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
62%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
74%
Advances
ODDS (%)
N/A
Bullish Trend 2 days ago
74%
Declines
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 12 days ago
75%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
73%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
ANIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LGND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MRSAX25.970.14
+0.54%
MFS Research International A
NMPAX14.21N/A
N/A
Columbia Mid Cap Index Inst
DGFYX31.78-0.07
-0.22%
Davis Global Y
NWHYX14.53-0.05
-0.34%
Nationwide Geneva Mid Cap Gr Instl Svc
OBGIX34.24-0.24
-0.70%
Oberweis Global Opportunities Instl

ANIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANIX has been loosely correlated with LGND. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ANIX jumps, then LGND could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANIX
1D Price
Change %
ANIX100%
-1.00%
LGND - ANIX
37%
Loosely correlated
+2.56%
GLUE - ANIX
33%
Loosely correlated
+3.55%
KLTO - ANIX
33%
Loosely correlated
-3.99%
IBRX - ANIX
32%
Poorly correlated
+1.46%
VERA - ANIX
32%
Poorly correlated
+0.35%
More

LGND and

Correlation & Price change

A.I.dvisor indicates that over the last year, LGND has been loosely correlated with CRSP. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if LGND jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LGND
1D Price
Change %
LGND100%
+2.56%
CRSP - LGND
52%
Loosely correlated
-2.38%
SYRE - LGND
51%
Loosely correlated
N/A
AGIO - LGND
51%
Loosely correlated
-3.51%
AXON - LGND
49%
Loosely correlated
-3.27%
ACLX - LGND
47%
Loosely correlated
-0.91%
More